| Company/Division name | Jubilant HollisterStier |
| Parent company | Jubilant Pharma Limited |
| Type of work | Manufacturing |
| If manufacturing, is the company a contract manufacturer? | Yes |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2021 |
| Domestically, the work will be done: | Both |
| City reshored to: | Spokane |
| State(s) reshored to: | WA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals, Biopharmaceutical |
| Product(s) reshored | biopharmaceuticals, COVAXIN™, COVID-19 vaccine |
| What domestic positive factors made reshoring more attractive? | Impact on domestic economy, Lead time/Time to market, Under-utilized capacity, Other, import replacement, Covid-19 |
